Author:
Malone Christopher D.,Mattrey Robert F.,Fetzer David T.
Publisher
Springer Science and Business Media LLC
Reference93 articles.
1. Mattrey RF, Scheible FW, Gosink BB, Leopold GR, Long DM, Higgins CB. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology. 1982;145(3):759–62.
2. Mattrey RF, Strich G, Shelton RE, Gosink BB, Leopold GR, Lee T, et al. Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results. Radiology. 1987;163(2):339–43.
3. First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use [press release]. 2016.
4. Schneider M. Characteristics of SonoVue trade mark. Echocardiography. 1999;16(7, Pt 2):743–6.
5. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33(2):318–25.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献